Strive Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96.2K Buy
+678
New +$109K 0.03% 285

Other funds holding NBIX

Strive Financial Group's NBIX Position: Q3 2026 in Review

Strive Financial Group opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 678 shares worth $96.2K. The stake represents 0.03% of the portfolio and ranks #285 among its holdings.

766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Strive Financial Group held 678 shares of Neurocrine Biosciences worth $96.2K as of Q3 2026.
  • Neurocrine Biosciences was a new Strive Financial Group position in Q3 2026.
  • Neurocrine Biosciences made up 0.03% of Strive Financial Group's portfolio in Q3 2026, its #285 holding.
  • 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Strive Financial Group's 13F filing for Q3 2026, filed 9 Nov 2026.